Cwm LLC Sells 211 Shares of Penumbra, Inc. (NYSE:PEN)

Cwm LLC decreased its holdings in Penumbra, Inc. (NYSE:PEN) by 29.2% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 511 shares of the company’s stock after selling 211 shares during the period. Cwm LLC’s holdings in Penumbra were worth $129,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in the business. RiverPark Advisors LLC acquired a new stake in Penumbra during the 3rd quarter valued at $42,000. Signaturefd LLC lifted its stake in shares of Penumbra by 27.2% during the 4th quarter. Signaturefd LLC now owns 215 shares of the company’s stock worth $54,000 after buying an additional 46 shares during the last quarter. Covestor Ltd boosted its holdings in shares of Penumbra by 357.9% during the 3rd quarter. Covestor Ltd now owns 348 shares of the company’s stock worth $84,000 after buying an additional 272 shares during the period. Nisa Investment Advisors LLC grew its stake in Penumbra by 496.7% in the 4th quarter. Nisa Investment Advisors LLC now owns 358 shares of the company’s stock valued at $90,000 after buying an additional 298 shares during the last quarter. Finally, Fifth Third Bancorp raised its holdings in Penumbra by 13.9% in the 4th quarter. Fifth Third Bancorp now owns 378 shares of the company’s stock valued at $95,000 after acquiring an additional 46 shares during the period. 88.88% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

PEN has been the subject of a number of research analyst reports. Canaccord Genuity Group restated a “buy” rating and set a $284.00 price objective on shares of Penumbra in a report on Friday, February 23rd. Piper Sandler reaffirmed an “overweight” rating and issued a $290.00 price objective on shares of Penumbra in a report on Wednesday, April 3rd. TheStreet raised Penumbra from a “d+” rating to a “c-” rating in a report on Friday, January 12th. JPMorgan Chase & Co. downgraded shares of Penumbra from an “overweight” rating to a “neutral” rating and decreased their price target for the company from $284.00 to $250.00 in a research note on Friday, February 23rd. Finally, Royal Bank of Canada reiterated an “outperform” rating and issued a $289.00 price objective on shares of Penumbra in a research note on Friday, February 23rd. Three research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat.com, Penumbra currently has an average rating of “Moderate Buy” and a consensus target price of $304.45.

Insider Buying and Selling

In other Penumbra news, EVP Johanna Roberts sold 600 shares of the firm’s stock in a transaction that occurred on Friday, March 1st. The shares were sold at an average price of $237.68, for a total value of $142,608.00. Following the sale, the executive vice president now owns 62,997 shares in the company, valued at $14,973,126.96. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other Penumbra news, EVP Johanna Roberts sold 600 shares of the company’s stock in a transaction dated Friday, March 1st. The stock was sold at an average price of $237.68, for a total value of $142,608.00. Following the completion of the transaction, the executive vice president now owns 62,997 shares of the company’s stock, valued at approximately $14,973,126.96. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Don W. Kassing sold 170 shares of Penumbra stock in a transaction dated Monday, April 1st. The shares were sold at an average price of $223.18, for a total value of $37,940.60. Following the sale, the director now directly owns 1,175 shares in the company, valued at $262,236.50. The disclosure for this sale can be found here. Insiders sold a total of 9,648 shares of company stock worth $2,369,903 in the last three months. 5.30% of the stock is owned by corporate insiders.

Penumbra Trading Up 1.2 %

Shares of PEN stock opened at $208.55 on Monday. Penumbra, Inc. has a fifty-two week low of $180.93 and a fifty-two week high of $348.67. The stock’s fifty day moving average price is $222.48 and its two-hundred day moving average price is $231.96. The company has a debt-to-equity ratio of 0.02, a quick ratio of 3.49 and a current ratio of 6.06. The company has a market cap of $8.08 billion, a PE ratio of 90.28, a P/E/G ratio of 2.06 and a beta of 0.57.

Penumbra (NYSE:PEN) last released its quarterly earnings data on Thursday, February 22nd. The company reported $0.76 earnings per share for the quarter, beating the consensus estimate of $0.71 by $0.05. The business had revenue of $284.68 million for the quarter, compared to analyst estimates of $286.62 million. Penumbra had a return on equity of 7.49% and a net margin of 8.59%. Penumbra’s revenue was up 28.7% compared to the same quarter last year. During the same period last year, the firm posted $0.16 earnings per share. Equities analysts predict that Penumbra, Inc. will post 2.85 EPS for the current fiscal year.

Penumbra Company Profile

Penumbra, Inc, together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.